Document is current
Any future updates will be listed below
-
Authors
Orozco Leal, Giovany https://orcid.org/0000-0002-7473-7318
Armstrong, Nigel https://orcid.org/0000-0002-7443-4798
Kernohan, Ashleigh https://orcid.org/0000-0002-5514-3186
Ahmadu, Charlotte https://orcid.org/0000-0001-6420-9071
Coughlan, Diarmuid https://orcid.org/0000-0002-5348-3750
McDermott, Kevin https://orcid.org/0000-0002-9415-8647
Duffy, Steven https://orcid.org/0000-0001-7335-8167
O’Meara, Susan https://orcid.org/0000-0002-3448-2234
Robinson, Tomos https://orcid.org/0000-0001-8695-9738
Vale, Luke https://orcid.org/0000-0001-8574-8429
Kleijnen, Jos
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme (NIHR135447)
- License Information
-
More Information
Article History
Accepted: 23 February 2023
First Online: 23 March 2023
Declarations
:
: The draft of this manuscript was written by Giovany Orozco Leal and all authors had the chance to comment on previous versions of the manuscript. All authors contributed to the study conception and design and all authors were involved with the work of the ERG. Nigel Armstrong acted as project lead, health economist and systematic reviewer on this assessment, critiqued the clinical effectiveness and cost effectiveness methods and evidence, and contributed to the writing of the report. Luke Vale acted as health economic project lead, critiqued the company’s economic evaluation, and contributed to the writing of the report. Giovany Orozco Leal, Diarmuid Coughlan, Tomos Robinson, Asheigh Kernohan and Charlotte Ahmadu acted as health economists on this assessment, critiqued the company’s economic evaluation and contributed to the writing of the report. Susan O’Meara and Kevin McDermott acted as systematic reviewers, critiqued the clinical effectiveness methods and evidence, and contributed to the writing of the report. Steven Duffy critiqued the search methods in the submission and contributed to the writing of the report. Jos Kleijnen critiqued the company’s definition of the decision problem and their description of the underlying health problem and current service provision, contributed to the writing of the report, and supervised the project.
: This project was commissioned by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (NIHR135447). See the HTA programme website for further project information (). This summary of the ERG report was compiled after NICE issued the FAD. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of NICE or the Department of Health.
: Giovany Orozco Leal, Nigel Armstrong, Asheigh Kernohan, Charlotte Ahmadu, Diarmuid Coughlan, Kevin McDermott, Steven Duffy, Susan O’Meara, Tomos Robinson, Luke Vale, and Jos Kleijnen have no conflicts of interest to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
